燕八哥医疗
esp包含燕八哥医疗
ESP矩阵利用数据和分析识别和了解排名领先的公司在一个给定的技术格局。
家庭的尿液分析市场使得家庭尿液收集和分析使用试纸条或包,附着在厕所和使用机器学习和计算机视觉分析样本。尿液测试通常测量生物标志物如葡萄糖、蛋白质、硝酸盐、酮、和肌酐检测糖尿病、肾脏疾病、尿路感染。这些家庭验尿…
燕八哥医学命名为挑战者在7其他公司,包括Healthy.io,LetsGetChecked,TestCard。
燕八哥医疗的产品和优势
UrinDx
一个在家连续尿诊断平台患者尿流生物物理变化的AI和护士的云基础设施。
集合包含燕八哥的医疗专家
专家集合是analyst-curated列表,突出了公司你需要知道的最重要的技术空间。
燕八哥医疗中6专家集合,包括医疗设备。
医疗设备
8633件
公司发展医疗器械(每IMDRF的“医疗器械”的定义)。包括软件、lab-developed测试(LDTs)和组合产品。*列更新尽可能经常。
数字医疗
10540件
数字健康收藏品包括供应商开发软件、平台、传感器和机器人硬件,在医疗健康数据基础设施和tech-enabled服务。列表中不包括制药/生物制药、测序仪器,基因编辑和辅助技术。
远程医疗
2856件
公司开发、提供或使用电子和通讯技术来促进健康和健康服务的提供从一个距离。*列尽可能经常更新;优先给公司和/或最近的资金。
健康监测与诊断
842件
公司提供的产品,帮助评估病人的健康状况和幸福的距离。标记为# RemoteMonitoring&Diagnostics
它的健康
8881件
数字健康150
150件
最新的燕八哥医疗新闻
2023年2月6日
在寻求提供高质量的医疗保健,容易获得和负担,简单的诊断检测HealthKit正在扩大其投资组合包括糖尿病、性健康和“tripledemic”COVID,流感和RSV。简单HealthKit操作在全球糖尿病诊断市场预计到2026年达到424亿美元,全球性病市场预测在2030年价值1410亿美元。诊断市场也使家庭的重大转变,由Everlywell等公司,并辅以初创企业世界各地,包括Senzo Healthtracka, TBD健康,燕八哥医疗和Hormona。椎名以外,生物化学和生物工程博士学位,2018年开始简单HealthKit团队,包括Jerzy Majka,李纳斯Aranha和丽莎Le,所有的使命是提供一个以人为中心的医疗方法,尤其是欠发达市场。目前与大型零售商、药房、教育机构、雇主和公共卫生组织代表超过150万人的社区。简单HealthKit诊断测试。影像学分:简单HealthKit“医疗对我们来说是一个复杂的问题,”德梅内塞斯对TechCrunch说。“当组织建立测试、实验室、远程医疗和处方,通常建在筒仓。常常,人们在其中任何一个周期下降,当这种情况发生时,个人没有得到照顾。“简单HealthKit开始与家庭或在诊所诊断呼吸健康和慢性病已经成为一个端到端的平台建立之后,它的诊断和临床实验室改进Amendments-certified实验室设施进行测试。 This means the company can return test results within 24 hours. Tests for sexual health and respiratory illness are available on the company’s website and are typically covered by health savings programs, while in-clinic or in-pharmacy tests are typically reimbursable through health insurance, according to the company. Menezes noted that the fast turnaround for testing was important because one in two sexually active people will contract a sexually transmitted disease by age 25, and many are asymptomatic, so they are unaware they have it. In addition, 37 million in the U.S. have diabetes , but 8.5 million are undiagnosed. “These are big challenges, especially in communities of color,” she added. “That’s where we’re reinvesting a lot of our profits in infrastructure, product lines and programs with different partners.” It also works with pharmacies and provides telehealth services for treatment and follow-up care. In addition, the company can plug its infrastructure into other organization’s workflow via an open-ended API or Health Level Seven application layer. Company plans for this year include continued work with its partners to accelerate physician-ordered diagnostic access in underserved communities. Menezes declined to disclose yearly revenue “due to upcoming movements,” but did say that testing volume between 2021 and 2022 grew 42%, and that as Simple HealthKit expands its product offerings, she is forecasting potential annual recurring revenue of $107 million. Much of the company’s growth has followed an $8 million round of Series A funding the company closed in 2021, but had not announced. It was led by Initialized Capital with participation from seed investors Kleiner Perkins, Kapor Capital and Quest Venture Partners. This brings Simple HealthKit’s total funding to date to $12 million. “Simple HealthKit is transforming traditional diagnostics with a human-centric approach, providing accessible testing tools in tandem with thoughtful follow-up care,” said Garry Tan, partner and founder at Initialized, Y Combinator president and CEO, and Simple HealthKit board member, in a written statement. “We believe this approach to diagnostics-as-a-service will be especially impactful in underserved markets where time and cost are often factors in whether or not people pursue care.”
燕八哥医疗常见问题(FAQ)
燕八哥医疗是何时成立的?
燕八哥医疗成立于2019年。
燕八哥医疗的总部在哪里?
燕八哥医疗总部位于后者街7505号,休斯顿。
燕八哥医学的最新一轮融资是什么?
燕八哥医学的最新一轮融资是种子VC。
燕八哥医疗筹集了多少钱?
燕八哥医疗筹集了总计4.24美元。
燕八哥医疗的投资者是谁?
燕八哥医疗的投资者包括Y Combinator, Innospark企业,罗杰斯家庭基金会,神奇的基金,雷米公司和12。
燕八哥医疗提供什么产品?
燕八哥医疗的产品包括UrinDx。